Product image of Ilgesin (Naproxen Sodium) supplied by GNH India

Ilgesin

Active Ingredient:
Naproxen Sodium
Origin:
EU

Ilgesin (Naproxen Sodium)

Naproxen sodium, the active ingredient in Ilgesin, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is used to relieve mild to moderate pain, reduce inflammation, and lower fever in adults, and is indicated for conditions such as osteoarthritis, rheumatoid arthritis, and dysmenorrhea.

GNH India supplies Ilgesin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Ilgesin (naproxen sodium) is an NSAID that targets inflammatory pathways to manage various pain‑related conditions.
  • Mild to moderate pain: provides analgesic relief for acute or chronic discomfort.
  • Inflammation: reduces swelling and redness associated with musculoskeletal disorders.
  • Fever: lowers elevated body temperature in febrile states.
  • Osteoarthritis: improves joint function and decreases pain in degenerative joint disease.
  • Rheumatoid arthritis: helps control inflammatory activity and joint pain.
  • Dysmenorrhea: alleviates menstrual‑related cramping and discomfort.

How It Works

  • Naproxen sodium reversibly inhibits cyclooxygenase‑1 (COX‑1) and cyclooxygenase‑2 (COX‑2) enzymes, decreasing the conversion of arachidonic acid to prostaglandins. The reduced prostaglandin synthesis diminishes inflammation, pain signaling, and fever generation at the site of tissue injury or disease.

Side Effects

Like other NSAIDs, naproxen sodium may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

  • Gastrointestinal upset (nausea, dyspepsia, abdominal pain)
  • Headache
  • Dizziness
  • Mild skin rash or itching

Serious or Rare Side Effects

  • Gastrointestinal bleeding or ulcer perforation
  • Cardiovascular events such as myocardial infarction or stroke
  • Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis)
  • Acute renal impairment or failure

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

  • Assess renal function: avoid or adjust use in patients with significant kidney impairment.
  • Evaluate cardiovascular risk: use cautiously in individuals with a history of heart disease or stroke.
  • Review gastrointestinal history: consider gastro‑protective agents for patients with prior ulcers.
  • Monitor for hypersensitivity: discontinue if severe allergic reactions develop.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Avoid Interactions

Naproxen sodium can interact with several drug classes, influencing safety or efficacy.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
  • Selective serotonin reuptake inhibitors (SSRIs): heightened hemorrhage potential.
  • Lithium: naproxen may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely)

  • ACE inhibitors or ARBs: possible reduction in renal function when combined.
  • Diuretics: may exacerbate renal impairment.
  • Methotrexate: naproxen can decrease methotrexate clearance, raising toxicity risk.

Frequently Asked Questions

Ilgesin contains naproxen sodium, an NSAID that is commonly prescribed to relieve mild to moderate pain, reduce inflammation, and lower fever. It is indicated for osteoarthritis, rheumatoid arthritis, dysmenorrhea, and other inflammatory or painful conditions.

Naproxen sodium works by reversibly blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever responses.

The appropriate dose of Ilgesin is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health. Dosage instructions are provided on the prescription label and should be followed exactly as directed.

Safety of naproxen sodium in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Ilgesin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both naproxen sodium (Ilgesin) and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a slightly faster onset. Choice depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Ilgesin should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight, and ensure the packaging remains tightly closed until use.

Ilgesin is taken orally, usually with a full glass of water. It can be taken with or without food, but taking it with food or milk may reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, and acute kidney injury. Patients should be monitored for signs of these conditions and discontinue use if they occur.

Ilgesin should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal bleeding, severe heart failure, or severe renal impairment. It is also contraindicated in patients who have had a recent coronary artery bypass graft surgery.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Naproxen Sodium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT